Clinicogenomics: The next big leap in data
The genome sequence is invaluable in disease research and drug discovery. Optum is bringing together clinical and health economic data to innovate clinical genomics and generate evidence that accelerates understanding of disease.
Data expansion to accelerate solutions
The clinicogenomics program started by Optum® Life Sciences combines world-class genotype and phenotype data assets for better, faster, cheaper drug discovery and development. It also provides engagement and preventive information to patients, health care providers and health systems.
Join Dr. Brian Solow, chief medical officer, Optum Life Sciences, and Dr. Jill Hagenkord, chief medical officer, Optum® Clinical Genomics as they discuss this next big leap in real-world data.